Quick blood transfusions may keep seniors Clear-Headed after hip surgery

NCT ID NCT06938789

Recruiting now Disease control Sponsor: University of Aarhus Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving blood transfusions quickly when hemoglobin drops can prevent delirium (sudden confusion) in patients 75 and older after hip fracture surgery. About 198 participants will be randomly assigned to either early transfusion or standard care. Researchers will check for delirium three times a day for two days after surgery and follow up at 30 and 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Blood transfusion
What this could lead to: If it works, this could point toward a simple way to prevent delirium after hip fracture surgery in older patients.
What could go wrong: This is a small, early-stage trial (198 participants) testing a common intervention, so the benefit may be modest or not statistically significant. Delirium has many causes, so preventing it with transfusions alone may not be enough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergence Delirium Hemorrhage hemorrhagic disease hip fracture delirium prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLEEDING DELIRIUM - POSTOPERATIVE HIP FRACTURE

Contacts and locations

Locations

Aarhus University Hospital
NOT_YET_RECRUITING

Aarhus, Central Jutland, 8200, Denmark
Gødstrup Hospital, Department of internal medicine
RECRUITING

Herning, Central Jutland, 7400, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.